CLDI.WS
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
CLDI.WS
Delisted
CLDI.WS was delisted on the 17th of October, 2024.
15 hedge funds and large institutions have $282K invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
2
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$17K
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$2.97K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$109 |